Published Date : 2024-Sep-20
The Global Diabetes Care Devices Market has experienced rapid growth in recent years due to the increasing prevalence of diabetes worldwide and advancements in medical technology. These devices, ranging from blood glucose monitors to insulin delivery systems, play a crucial role in managing the disease, ensuring better quality of life for patients.
In this blog, we explore some of the top companies leading in the diabetes care devices market, including Medtronic, Roche Diabetes Care, Abbott Laboratories, Dexcom, Tandem Diabetes Care, Ascensia Diabetes Care, Ypsomed, Novo Nordisk and more.
Diabetes Care Devices Market Size, Share & Trends Analysis Report By Type (Blood Glucose Monitoring Devices (Testing Strips, Self-monitoring Blood Glucose Meters, Lancets, Continuous Glucose Monitors, Others), Insulin Delivery Devices (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors)), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, (2023-2031).
The Diabetes Care Devices market research report comprises a thorough examination of the current and future scenario of this industry vertical. The research highlights major trends and opportunities, as well as challenges, for various segments and sub-segments, while broadening the company horizon. The study report also includes extensive information based on past and present patterns across several industry verticals to help find various expansion prospects. Throughout the forecast period, several estimations regarding market share, market size, and industry growth rate are presented. The research includes information on competitive analysis as well as consumption habits and pricing strategies depending on the Diabetes Care Devices market.
Get Insights: https://www.intellectualmarketinsights.com/report/diabetes-care-devices-market-research-current-trends-and-growth/imi-005222
Overview: Medtronic is an American Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Dublin, Ireland and founded in 1949. It operates in more than 150 countries and employs over 90,000 people.
The company is a global leader in medical technology and has made significant strides in the diabetes care sector. Their MiniMed insulin pumps and continuous glucose monitoring (CGM) systems have been game-changers for patients requiring continuous insulin delivery. Medtronic’s CGM systems, like the Guardian™ Connect, offer real-time glucose monitoring with predictive insights, allowing users to better manage their blood sugar levels.
Key Products: MiniMed Insulin Pumps, Guardian™ Connect CGM
Overview: Roche is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. The company headquarters is in Basel, Switzerland and founded in 1896.
The company is renowned for its Accu-Chek line of blood glucose monitoring systems, which have long been trusted by patients and healthcare professionals. With a focus on improving ease of use and connectivity, Roche continues to innovate by integrating digital health solutions to provide personalized diabetes management.
Key Products: Accu-Chek Guide, Accu-Chek Instant
Overview: Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States and founded in 1888.
The company has transformed diabetes care with its FreeStyle Libre flash glucose monitoring system. This revolutionary device allows users to monitor glucose levels without the need for finger pricks, offering a painless and continuous glucose monitoring experience. Abbott’s FreeStyle Libre systems have garnered immense popularity globally, and the company continues to improve the technology to increase accessibility.
Key Products: FreeStyle Libre, FreeStyle Libre 2, FreeStyle Libre 3
Overview: Dexcom is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California and founded in 1999.
The company is a leader in continuous glucose monitoring (CGM) systems, and its G-series devices are some of the most trusted by people living with diabetes. The Dexcom G6 system provides real-time glucose data through a wearable sensor, and its app delivers data straight to smartphones or smartwatches. Dexcom is dedicated to making diabetes management more accessible and less intrusive through its CGM technology.
Key Products: Dexcom G6, Dexcom G7
Overview: Tandem Diabetes Care is an American medical device manufacturer based in San Diego, California, U.S. and founded in 2006. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
Tandem Diabetes Care interviewed more than 4,000 insulin pump users and health care providers to design its first device, the X2™ Insulin Pump
Tandem Diabetes Care has gained a reputation for its user-friendly insulin pumps, particularly the t:X2™ insulin pump. This pump integrates with Dexcom CGM systems and allows users to receive automatic insulin adjustments. With a sleek, touchscreen design, Tandem’s devices have revolutionized the user experience, blending cutting-edge technology with comfort.
Key Products: T X2™ Insulin Pump
Overview: Ascensia Diabetes Care Swiss continuous glucose monitoring systems for diabetes equipment manufacturers company. Founded in 2015, the company is headquarters in Basel, Switzerland. The company and products are sold in more than 125 countries worldwide.
A global leader in blood glucose monitoring, Ascensia Diabetes Care is known for its Contour® range of products. The company focuses on simplifying diabetes management through its easy-to-use devices that offer fast and accurate results. Ascensia’s smart systems provide advanced data insights, helping users make informed decisions about their diabetes care.
Key Products: Contour® NEXT One, Contour® PLUS One
Overview: Ypsomed is a Swiss company that founded 2003 in and headquarters in Switzerland.
The company is a Swiss-based company that has been pioneering diabetes care with its mylife™ insulin delivery products. Their focus is on user-friendly and flexible systems for self-care, including insulin pumps and pen systems. Ypsomed aims to empower users with the freedom to manage their condition independently.
Key Products: mylife™ YpsoPump
Overview: Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark and founded in 1923.
While Novo Nordisk is primarily known for its insulin and diabetes medication, the company has also entered the device market with its smart insulin pens and connected solutions. NovoPen® 6 and NovoPen® Echo Plus are examples of devices that help users track insulin doses and connect with digital platforms for real-time monitoring.
Key Products: NovoPen® 6, NovoPen® Echo Plus
By Type | By Region |
Blood Glucose Monitoring Devices
Insulin Delivery Devices
| North America Europe Asia-Pacific Middle East South America |
The diabetes care devices market continues to evolve, with major players like Medtronic, Abbott, Dexcom, and Roche driving innovation. From continuous glucose monitoring to smart insulin delivery systems, these companies are developing new technologies that not only make managing diabetes easier but also empower patients with better control over their condition. As the prevalence of diabetes rises globally, these advancements will play a vital role in improving the quality of life for millions of individuals.
Intellectual Market Insights Research is a global market intelligence and consulting organisation that provides syndicated research reports, customised research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, Aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of subdomains under the sun. We create value for clients through our highly reliable and accurate reports.
Mr. Smit Patel
Phone: +1 (814) 487 8486
Email: smit@intellectualmarketinsights.com
Corporate Sales: sales@intellectualmarketinsights.com
